ArticleCureus2023
Endoscopic Resection of Pseudoarticulation as a Treatment for Bertolotti's Syndrome.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 11 citations in OpenAlex.
- Robotic-assisted minimally invasive excision of Bertolotti syndrome: novel technique and feasibility.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026Article
- Unilateral biportal endoscopic spinal surgery for the treatment of Bertolotti syndrome in an adolescent, a case report.Frontiers in surgery · 2026Article
- Full-endoscopic Spine Surgery for the Treatment of Far-out Syndrome: A Case Series.Neurologia medico-chirurgica · 2025Article
- Minimally invasive full endoscopic resection of the anomalous transverse process in Bertolotti's syndrome: illustrative case.Journal of neurosurgery. Case lessons · 2025Article
- Prevalence, diagnosis, and clinical significance of lumbosacral transitional vertebrae: A systematic review and narrative analysis.Brain & spine · 2025Review
- Article
- An update on the prevalence and management of Bertolotti's syndrome.Frontiers in surgery · 2024Review
- Techniques for restoring optimal spinal biomechanics to alleviate symptoms in Bertolotti syndrome: illustrative case.Journal of neurosurgery. Case lessons · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bertolotti's syndrome is described as lower back pain with the presence of lumbosacral transitional vertebrae (LSTV) associated with an articulation, pseudoarticulation, or full fusion of the transverse process to the sacrum and ilium. We present a unique case of the management of a 57-year-old woman with treatment-resistant lower back pain who underwent endoscopic resection of a pseudoarticulation related to LSTV. The patient underwent multiple treatment regimens without achieving satisfactory relief. These included physical therapy, sacroiliac (SI) joint injections, radiofrequency lesioning at multiple levels, and spinal cord stimulator placement. Relief with injection at the patient's pseudoarticulation confirmed this as a contributor to the patient's back pain. Interventional management of Bertolotti's syndrome can include different modalities, most recently including minimally invasive surgical techniques. This patient experienced partial relief of lower back pain after undergoing minimally invasive resection of the pseudoarticulation. This case demonstrates the benefit of a minimally invasive resection of this anatomic abnormality in a patient who has undergone previous treatments. Isolating this anomaly as a source of pain is necessary to ensure a favorable response and prevent needless surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.